News

All Releases
View Summary Sophiris Bio Reports Administrative Interim Analysis for the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia
Dec 15, 2014
PDF 14.0 KB Add to Briefcase
View Summary Sophiris Bio to Present at the 26th Annual Piper Jaffray Healthcare Conference
Nov 25, 2014
PDF 13.6 KB Add to Briefcase
View Summary Sophiris Bio Reports Third Quarter Financial Results
Nov 12, 2014
PDF 24.7 KB Add to Briefcase
View Summary Sophiris Bio to Present at the Stifel 2014 Healthcare Conference
Nov 7, 2014
PDF 14.1 KB Add to Briefcase
View Summary Sophiris Bio to Present at the 13th Annual BIO Investor Forum
Sep 30, 2014
PDF 14.0 KB Add to Briefcase
View Summary Sophiris Bio Reports Completion of Enrollment in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia
Sep 2, 2014
PDF 13.8 KB Add to Briefcase
View Summary Sophiris Bio Reports Second Quarter Financial Results and Key Operational and Financial Highlights
Aug 7, 2014
PDF 24.3 KB Add to Briefcase
View Summary Sophiris Bio to Present at the Jefferies 2014 Global Healthcare Conference
May 22, 2014
PDF 13.9 KB Add to Briefcase
View Summary Sophiris Enters into Common Stock Purchase Agreement with Aspire Capital to Support Proof of Concept Study of PRX302 in Prostate Cancer
May 19, 2014
PDF 15.9 KB Add to Briefcase
View Summary Sophiris Bio Reports First Quarter Financial Results
May 13, 2014
PDF 22.0 KB Add to Briefcase
View Summary Sophiris Bio to Present at the 13th Annual Needham Healthcare Conference
Mar 25, 2014
PDF 13.5 KB Add to Briefcase
View Summary Sophiris Adds Gerald T. Proehl to its Board of Directors
Mar 20, 2014
PDF 14.9 KB Add to Briefcase
View Summary Sophiris Bio Reports Fourth Quarter and Full Year 2013 Financial Results and Key Operational Highlights
Mar 13, 2014
PDF 35.4 KB Add to Briefcase
View Summary Sophiris Bio to Present at the Cowen and Company 34th Annual Health Care Conference
Feb 26, 2014
PDF 13.6 KB Add to Briefcase
View Summary Sophiris Bio to Present at the 2014 Leerink Global Healthcare Conference
Feb 3, 2014
PDF 14.0 KB Add to Briefcase
View Summary Sophiris Bio Reports Third Quarter Financial Results and Recent Key Operational Highlights
Nov 12, 2013
PDF 36.1 KB Add to Briefcase
View Summary Sophiris Bio Applies for Voluntary Delisting from TSX
Nov 5, 2013
PDF 13.2 KB Add to Briefcase
View Summary Sophiris Announces First Patients Dosed in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia
Oct 28, 2013
PDF 13.6 KB Add to Briefcase
View Summary Sophiris Bio to Present at the Stifel Healthcare Conference
Sep 5, 2013
PDF 11.3 KB Add to Briefcase
View Summary Sophiris Bio Closes $65 Million Public Offering
Aug 23, 2013
PDF 11.0 KB Add to Briefcase
Showing 41-60 of 75 Page: 1 2 3 4  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase